SPTX insider trading — Seaport Therapeutics, Inc.
Over the last 90 days, insiders at Seaport Therapeutics, Inc. (SPTX) made 1 open-market purchase worth $99K and 0 open-market sales worth $0, making them net buyers by $99K. The largest purchase was by Torres Denice (Director), who bought 5,000 shares for $99K on Nov 3, 2026.
Updated Nov 5, 2026.
Recent SPTX insider transactions
Every Form 4 filed by Seaport Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Torres Denice | Director | P · Purchase | Direct | 5,000 | $19.86 | $99K | Form 4 |
SPTX insider trading FAQ
Are insiders buying SPTX stock?
Yes. In the last 90 days, Seaport Therapeutics, Inc. insiders made 1 open-market purchase totaling $99K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading SPTX?
Recent buyers: Torres Denice.
Where does SPTX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.